Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$2.51B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.53B |
| 3 |
Amazon
AMZN
|
+$1.11B |
| 4 |
Airbnb
ABNB
|
+$574M |
| 5 |
NVIDIA
NVDA
|
+$519M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$588M |
| 2 |
NIO
NIO
|
+$539M |
| 3 |
Apple
AAPL
|
+$525M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$443M |
| 5 |
Microsoft
MSFT
|
+$375M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 90.77% |
| 2 | Consumer Discretionary | 1.94% |
| 3 | Technology | 1.9% |
| 4 | Communication Services | 1.42% |
| 5 | Financials | 1.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3876
PUT
Allot
ALLT
$381M
| $5.29M | ﹤0.01% |
266,600
+116,700
| +78% | +$2.15M |
|
|
TRHC
3877
CALL
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $5.29M | ﹤0.01% |
105,700
+47,700
| +82% | +$2.13M |
|
3878
iShares Core 10+ Year USD Bond ETF
ILTB
$595M
| $5.28M | ﹤0.01% |
73,091
+69,309
| +1,833% | +$4.86M |
|
3879
Kinsale Capital Group
KNSL
$8.67B
| $5.28M | ﹤0.01% |
32,059
-13,062
| -29% | -$2.16M |
|
3880
PUT
Natera
NTRA
$47B
| $5.28M | ﹤0.01% |
46,500
+26,800
| +136% | +$2.74M |
|
3881
CALL
Radian Group
RDN
$4.82B
| $5.28M | ﹤0.01% |
237,200
-42,900
| -15% | -$1M |
|
3882
CALL
Porch Group
PRCH
$1.98B
| $5.28M | ﹤0.01% |
272,800
+11,000
| +4% | +$181K |
|
|
MAXN
3883
DELISTED
Maxeon Solar Technologies
MAXN
| $5.27M | ﹤0.01% |
2,458
+1,534
| +166% | +$2.88M |
|
3884
iShares Russell Mid-Cap Growth ETF
IWP
$20.2B
| $5.25M | ﹤0.01% |
46,422
-161,036
| -78% | -$17.2M |
|
3885
iShares MSCI Japan ETF
EWJ
$22.7B
| $5.25M | ﹤0.01% |
77,788
+39,592
| +104% | +$2.71M |
|
3886
CALL
Shoals Technologies Group
SHLS
$1.2B
| $5.25M | ﹤0.01% |
148,000
-73,400
| -33% | -$2.21M |
|
3887
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.96B
| $5.25M | ﹤0.01% |
+74,812
| New | +$5.09M |
|
3888
PUT
Teradata
TDC
$2.68B
| $5.25M | ﹤0.01% |
105,100
-284,600
| -73% | -$12.9M |
|
3889
Vanguard Health Care ETF
VHT
$19.3B
| $5.25M | ﹤0.01% |
21,249
-14,132
| -40% | -$3.38M |
|
3890
Host Hotels & Resorts
HST
$15.3B
| $5.25M | ﹤0.01% |
307,153
+83,338
| +37% | +$1.45M |
|
3891
Ventas
VTR
$47.1B
| $5.25M | ﹤0.01% |
91,924
-18,108
| -16% | -$1.01M |
|
3892
CALL
Henry Schein
HSIC
$9.98B
| $5.25M | ﹤0.01% |
70,700
-1,800
| -2% | -$136K |
|
|
ITCI
3893
PUT
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $5.25M | ﹤0.01% |
128,500
-172,400
| -57% | -$6.37M |
|
3894
First Trust Multi Cap Growth AlphaDEX Fund
FAD
$584M
| $5.24M | ﹤0.01% |
43,840
+28,066
| +178% | +$3.16M |
|
3895
JPMorgan BetaBuilders Europe ETF
BBEU
$9.48B
| $5.24M | ﹤0.01% |
+89,419
| New | +$5.24M |
|
|
PR
3896
Permian Resources
PR
$19B
| $5.23M | ﹤0.01% |
771,941
-2,154,123
| -74% | -$11.1M |
|
3897
McCormick & Company Non-Voting
MKC
$14.9B
| $5.23M | ﹤0.01% |
59,244
+14,501
| +32% | +$1.29M |
|
3898
CALL
Alto Ingredients
ALTO
$316M
| $5.23M | ﹤0.01% |
856,100
+164,400
| +24% | +$956K |
|
|
ZUO
3899
CALL
DELISTED
Zuora, Inc.
ZUO
| $5.23M | ﹤0.01% |
303,200
+95,900
| +46% | +$1.53M |
|
3900
ProShares UltraPro Russell2000
URTY
$325M
| $5.23M | ﹤0.01% |
44,860
+5,203
| +13% | +$577K |
|
Similar funds
Jeff Yass's Q2 2021 Portfolio in Review
As of Q2 2021, Jeff Yass held 13,792 positions worth $712B, up 12% from $634B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jeff Yass's Q2 2021 filing shows 1,607 new, 5,174 increased, 5,388 reduced and 1,330 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 622,837 shares worth $103M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $588M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 91% a quarter earlier, followed by Consumer Discretionary and Technology.
- Jeff Yass's largest Q2 2021 buy was PRA Health Sciences, Inc.: 622,837 shares worth $103M.
- Jeff Yass added most to Walt Disney in Q2 2021, an estimated $2.51B increase.
- Jeff Yass's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $588M.
- Jeff Yass fully exited iShares Core MSCI EAFE ETF in Q2 2021, selling an estimated $59.3M.
- Jeff Yass's ten largest holdings make up 30% of its $712B portfolio in Q2 2021.
- Jeff Yass opened 1,607 new positions and closed 1,330 in Q2 2021.
- Jeff Yass's portfolio value rose 12% quarter-over-quarter to $712B.
Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.